Cite
HARVARD Citation
Almas, S. et al. (n.d.). P647 Outcomes following the use of vedolizumab first line versus second line in Ulcerative Colitis: a single centre experience. Journal of Crohn's and colitis. p. i777. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Almas, S. et al. (n.d.). P647 Outcomes following the use of vedolizumab first line versus second line in Ulcerative Colitis: a single centre experience. Journal of Crohn's and colitis. p. i777. [Online].